Advertisement
New Zealand markets closed
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NZD/USD

    0.5946
    +0.0011 (+0.19%)
     
  • NZD/EUR

    0.5550
    +0.0009 (+0.16%)
     
  • ALL ORDS

    7,948.00
    +10.10 (+0.13%)
     
  • ASX 200

    7,692.70
    +9.20 (+0.12%)
     
  • OIL

    83.53
    +0.17 (+0.20%)
     
  • GOLD

    2,340.00
    -2.10 (-0.09%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    17,174.84
    +345.91 (+2.06%)
     
  • NIKKEI 225

    38,412.53
    +860.37 (+2.29%)
     
  • NZD/JPY

    92.0060
    +0.2400 (+0.26%)
     

Cross Country Healthcare (CCRN) Gains As Market Dips: What You Should Know

Cross Country Healthcare (CCRN) closed the most recent trading day at $20.83, moving +0.39% from the previous trading session. This move outpaced the S&P 500's daily loss of 0.88%. At the same time, the Dow lost 0.82%, and the tech-heavy Nasdaq gained 0.08%.

Coming into today, shares of the provider of health care staffing and workforce management services had gained 19.53% in the past month. In that same time, the Business Services sector lost 8.95%, while the S&P 500 lost 8.06%.

Cross Country Healthcare will be looking to display strength as it nears its next earnings release. In that report, analysts expect Cross Country Healthcare to post earnings of $1.35 per share. This would mark year-over-year growth of 187.23%. Meanwhile, our latest consensus estimate is calling for revenue of $741.57 million, up 123.48% from the prior-year quarter.

Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.77 per share and revenue of $2.67 billion. These totals would mark changes of +55.88% and +59.45%, respectively, from last year.

ADVERTISEMENT

It is also important to note the recent changes to analyst estimates for Cross Country Healthcare. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.

Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 1.21% higher within the past month. Cross Country Healthcare is currently sporting a Zacks Rank of #1 (Strong Buy).

Valuation is also important, so investors should note that Cross Country Healthcare has a Forward P/E ratio of 4.35 right now. This valuation marks a discount compared to its industry's average Forward P/E of 10.25.

We can also see that CCRN currently has a PEG ratio of 0.63. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Staffing Firms was holding an average PEG ratio of 1.01 at yesterday's closing price.

The Staffing Firms industry is part of the Business Services sector. This group has a Zacks Industry Rank of 104, putting it in the top 42% of all 250+ industries.

The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cross Country Healthcare, Inc. (CCRN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.